Eli Lilly Says Weight-Loss Drug Helps Patients Lose 26% of Their Weight, More Than Rivals
Eli Lilly said that two Phase 3 trials of its weight-loss drug tirzepatide showed patients lost 26.6% of their body weight on average, more than competitors.
( 1
min )